Curae Pharma360 Promotes Autumn Ehnow To Chief Executive Officer
06/13/23, 3:51 PM
Location
san francisco
Industry
pharmaceutical
biotechnology
health care
Position
chief executive officer
Curae Pharma360 , a mission-driven pharmaceutical company strengthening access to and affordability of life-changing generic medicines, announced today it has promoted Autumn Ehnow to Chief Executive Officer. A founding leader of Curae and its Chief Operating Officer since the company's inception last year, Ehnow will continue to serve as Executive Vice President, Policy & Strategic Market Access at Medicines360, the nonprofit parent company of Curae.
Company Info
Location
san francisco, california, united states
Additional Info
A mission-driven pharmaceutical company committed to advancing equitable, reliable access to affordable medicines for everyone, Curae Pharma360 Inc. is a for-profit subsidiary of Medicines360, a nonprofit pharmaceutical organization. Building on its heritage from Medicines360, Curae will bring needed, life-changing medicines to market that stabilize supply chains and expand access for populations in need. Curae has two business units, an injectable oncology line, and a consumer health line offering the OTC emergency contraception Levonorgestrel Tablet 1.5 mg, otherwise known as the morning after pill. For more information, visit curaepharma.com.